One of the most significant trends in the API industry is the increasing focus on biologics. Biologics are complex molecules derived from living organisms, and they often require specialized manufacturing processes. This shift towards biologics represents both a challenge and an opportunity for API manufacturers.
Active Pharmaceutical Ingredients (APIs) play a crucial role in the pharmaceutical industry, serving as the essential components responsible for the therapeutic effects of medications. The quality, efficacy, and safety of a drug are directly linked to the quality of its API, making the understanding of these ingredients imperative for pharmaceutical development and manufacturing.
Mitochondria are essential organelles responsible for producing adenosine triphosphate (ATP), the energy currency of cells. As we age or face environmental stresses, the efficiency of our mitochondria can decline, leading to reduced energy levels, increased fatigue, and a higher susceptibility to chronic diseases. This is where PQQ comes into play, offering a promising avenue for promoting mitochondrial biogenesis—the process of creating new mitochondria.